Clinical trial

Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

NCT01482585

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention CT, PET, copy number alteration Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2011-10-01

PhaseN/A

Conditions

Lung Adenocarcinomaverified · MONDO: lung adenocarcinoma

Interventions

CT, PET, copy number alterationOTHER

Sponsors & collaborators

Samsung Medical Centerlead sponsor

Korean Foundation for Cancer Researchcollaborator

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01482585 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.